ACADIA Pharmaceuticals Price Target Cut to $33.00/Share From $40.00 by Citigroup
Ratings actions from Benzinga: GMT) ACADIA Pharmaceuticals Is Maintained at Buy by CitigroupRatings actions from Benzinga
Ratings actions from Benzinga: GMT) ACADIA Pharmaceuticals Is Maintained at Buy by CitigroupRatings actions from Benzinga